Zurueck zur Suche

Reporte zur Charge U7616AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

24Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 4 TX 4 SC 2 GA 2 MA 2 NM 1 ID 1 AR 1 MS 1 CO 1 CA 1 OK 1

VAERS 2724132

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
NM
Alter
11,0
Geschlecht
F
Eingang
14.12.2023
Impfdatum
05.12.2023
Beginn
05.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose normal Oxygen saturation decreased Syncope

Symptomtext

At 1415 mother stated that the patient fainted. Vital signs at 1420 B/P 118/75, HR 67, O2 93 %, At 1423 patient was placed on oxygen at 2LPM due to oxygen dropped to 83 %. at this time Ice was placed on chest per provider. At 1423 B/P was at 144/74 and HR 82, a blood sugar was performed, blood sugar was at 93. At 1424 02 was at 100% at this time O2 was lowered per provider to 1 LPM. At 1425 patient started to respond to O2 at this time was at 100% room air, HR 79. Patient remained in room at 1502 patient vitals were at 99% O2, HR 74 and B/P 103/67 at this time patient was in sitting position and was responding to questions asked by PA. At 1509 patient was asked to walk in the hallway to see if she was ok and she was not feeling dizzy at this time patient denied feeling dizzy and was released to go home with mother. Mother and patient had no further questions at this time. Patient was in today for Immunization shots

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2686448

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
SC
Alter
15,0
Geschlecht
M
Eingang
26.09.2023
Impfdatum
25.09.2023
Beginn
25.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

During administration of vaccines client experienced brief episode of syncope. Client returned to consciousness within a few seconds. Parent present. Client placed in supine position with legs elevated. Within 10 minutes client stated no dizziness or other symptoms. Client able to sit up and then stand up without difficulty or symptoms. Vital signs stable. No additional medical interventions necessary. Client ambulatory and accompanied by parent at discharge from clinic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2669440

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
ID
Alter
18,0
Geschlecht
M
Eingang
10.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Head injury Loss of consciousness

Symptomtext

Client passed out falling off the exam table to the floor, striking his forehead on the floor. He was rolled over onto his back, his mother cradled his head in her lap. Ice pack was placed on his head, he was given a juice box to drink. Client stayed on the floor for 15 minutes until he felt good enough to sit up. He then sat in a chair for 5 minutes before he left with his mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Client passed out falling off the exam table to the floor, striking his forehead on the floor. He was rolled over onto his back, his mother cradled his head in her lap. Ice pack was placed on his head, he was given a juice box to drink.
Allergien
None
Vorherige Impfungen
-

VAERS 2668570

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
OH
Alter
17,0
Geschlecht
M
Eingang
09.08.2023
Impfdatum
09.08.2023
Beginn
09.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Nausea Pallor Syncope

Symptomtext

Pt had a vasovagal response. He became pale and felt as though he could vomit. Pt was placed in supine position and given cold wash rag. He did eat a popsicle. Symptoms lasted about 4 minutes. VSS throughout this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Vital signs taken. HR 84, RR 20, O2 sats 97%
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2658245

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
OH
Alter
16,0
Geschlecht
M
Eingang
04.08.2023
Impfdatum
19.07.2023
Beginn
19.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bradycardia Hyperhidrosis Syncope

Symptomtext

Pt has an incident of syncope approx 5 mins after immunizations were given. B/p was 117/77 and pulse was 44 when pt returned to office. Pt give a granola bar and water. He hadn't eaten prior to the appointment. 2nd B/P 105/73 pulse 46. Condition continued to improve. 20 minutes after incident B/P was 100/65 and pulse was 51. Pt left the dept. Ambulating without assistance

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
Ketoconazole 2% topical, melatonin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2658245

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
OH
Alter
16,0
Geschlecht
M
Eingang
04.08.2023
Impfdatum
19.07.2023
Beginn
19.07.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bradycardia Hyperhidrosis Syncope

Symptomtext

Pt has an incident of syncope approx 5 mins after immunizations were given. B/p was 117/77 and pulse was 44 when pt returned to office. Pt give a granola bar and water. He hadn't eaten prior to the appointment. 2nd B/P 105/73 pulse 46. Condition continued to improve. 20 minutes after incident B/P was 100/65 and pulse was 51. Pt left the dept. Ambulating without assistance

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
Ketoconazole 2% topical, melatonin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2664909

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge u7616ab

schwer
Staat
SC
Alter
12,0
Geschlecht
M
Eingang
02.08.2023
Impfdatum
02.08.2023
Beginn
02.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope Vomiting

Symptomtext

After receiving the vaccines client had an episode of syncope lasting 1 minute. Client place flat on exam table. After 1 minute, client regained consciousness & place on left side in recovery position. Client vomited small amount of clear mucous. Mother states client did not eat prior to apointment. Client monitored for 10 minutes & offered soda. Client's color returned & able to ambulate without difficulty to parent's vehicle. Mother with client during the appointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664241

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7616AB

schwer
Staat
AR
Alter
13,0
Geschlecht
F
Eingang
01.08.2023
Impfdatum
01.08.2023
Beginn
01.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Head injury Syncope

Symptomtext

Pt had a vasovagal episode roughly about 2 minutes after receiving Menquadfi and Tdap vaccines about 08:56. She slowly fell from her chair face first. She hit her head on the floor but did not bruise. She appeared pale after episode. Nurses elevated her feet and fanned her. She quickly returned to be alert oriented and responsive. Blood pressure check was 102/72 at 9:00 am. pt sat up and ate some candy and her color returned prior to leaving clinic. Guardian states that she has a lot of anxiety.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
multivitamin, tylenol
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2659363

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
TX
Alter
11,0
Geschlecht
F
Eingang
21.07.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood test Fall Movement disorder Oral contusion Syncope

Symptomtext

HAD APPARENT VASOVAGAL EVENT AFTER IMM/ BLOOD DRAWING - CONTORTING MOVEMENTS AND EVENTUALLY FELL FORWARD FROM CHAIR-WAS LAID DOWN ON EXAM TABLE AND LEGS RAISED- EPISODE RESOLVED WITHING 5-10 MIN- SUSTAINED CONTUSSION TO RIGHT LOWER LIP TEETH INTACT- BLOOD PRESSURE WAS NORMAL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
BLOOD WORK DONE IN OFFICE
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
-

VAERS 2648670

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
MS
Alter
12,0
Geschlecht
F
Eingang
22.06.2023
Impfdatum
07.06.2023
Beginn
07.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Eye movement disorder Loss of consciousness

Symptomtext

Tdap and MenQuadfi given in R arm IM. HPV9 given IM in L arm. Patient sitting on table then moved to chair to sit but sister. Patient then stated within 2 minutes of last vaccine (HPV9) that she felt like she would pass out. Patient passed out on her sisters shoulder mom then picked her head up and childs eyes tolled back. The Dr. came in and laid child down on seat and monitored her for at least the next hour. Once patient felt ok, water given and family helped child to restroom and then left office. Nurse from our office called mom next day was doing better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Cough
Vorgeschichte
Asthma, Depression, Anxiety
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2646608

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

schwer
Staat
TX
Alter
18,0
Geschlecht
M
Eingang
17.06.2023
Impfdatum
16.06.2023
Beginn
16.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Syncope

Symptomtext

After receiving Second injection Patient experienced syncope/lightheadedness. Patient stated he hadn't eaten that morning. Patient also stated he Worked out the previous night and had not had much water. Patient given water and crackers and felt better after 30 min of observation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2693569

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

mild
Staat
CO
Alter
11,0
Geschlecht
F
Eingang
10.10.2023
Impfdatum
06.10.2023
Beginn
06.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Immediate post-injection reaction

Symptomtext

Patient became dizzy immediately following vaccine administration. Dizziness lasted several days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
history of prolonged dizziness following flu vaccine in the past
Vorherige Impfungen
prolonged dizziness after receiving influenza vaccine in the past

VAERS 2676192

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

mild
Staat
GA
Alter
16,0
Geschlecht
M
Eingang
24.08.2023
Impfdatum
24.08.2023
Beginn
24.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Approxiamtely three mins after patient received the MCV4 (Menquadfi) vaccine he c/o of feeling dizzy. At that time we propped his feet up in the chair, placed cool cloths on neck and face and turned on a cool fan. BP was check @2:29pm. 85/47 P-68. Patient was given a soda and some peanut butter crackers. Patients BP was checked again @2:32pm 96/57 P-64. BP was checked again @2:35pm 102/60 P-68. After 10 mins, patient stated that he was feeling better. No longer experiencing any dizziness. Advised grandmother to wait in the lobby an additional 15 mins for patient to be monitored and after that he can go. Also advised gandmother to get patient something to eat when they leave as patient stated that he had not had anything to eat all day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
BP @2:29pm- 85/47 P-68 BP @2:32pm- 96;57 P=64 BP @2:35pm- 102/60 P-68
Aktuelle Erkrankungen
None
Vorgeschichte
Hx of asthma
Andere Medikamente
none
Allergien
PCN, Amoxicillin, Apricots
Vorherige Impfungen
-

VAERS 2652835

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

mild
Staat
CA
Alter
11,0
Geschlecht
F
Eingang
05.07.2023
Impfdatum
03.07.2023
Beginn
04.07.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Peripheral swelling Pruritus

Symptomtext

Patient had swelling, redness, and itchiness on Left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
N/A.
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
NKDA.
Vorherige Impfungen
-

VAERS 2649959

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

mild
Staat
OK
Alter
12,0
Geschlecht
F
Eingang
27.06.2023
Impfdatum
16.06.2023
Beginn
16.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

MOP described patient "complaining" about arms after vaccine administrations. MOP presented pictures of reaction. Mild urticaria present, no redness or swelling. As of 06/26/2023, MOP reported that symptoms have cleared.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 2682286

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7616AB

gering
Staat
OH
Alter
0,6
Geschlecht
M
Eingang
15.09.2023
Impfdatum
08.09.2023
Beginn
08.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

reports that a 7-month old patient received menquadfi with no reported adverse event; Initial information received on 08-Sep-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 7-months-old male patient who received meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 13V (CRM197) (Prevnar 13); and Rotavirus Vaccine for Prophylactic vaccination (immunization). On 08-Sep-2023 at 09:00 hours, the 7-month old patient received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (T conj) vaccine, solution for injection (batch number: U7616AB via intramuscular route in the upper thigh NOS for Immunization with no reported adverse event (product administered to patient of inappropriate age) (same day latency). Reportedly, the MENQUADFI was given in error because the staff mixed up the vaccines. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 13; ROTAVIRUS VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2677904

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

gering
Staat
GA
Alter
16,0
Geschlecht
M
Eingang
30.08.2023
Impfdatum
30.08.2023
Beginn
30.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Diplopia Feeling abnormal Vision blurred

Symptomtext

Patient's step -father called to the HD and reports that he received a call from the school nurse stating that the patient was reporting "feeling weird, seeing double and having a hard time focusing".

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diplopia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none reported
Vorgeschichte
none reported
Andere Medikamente
none that I am
Allergien
none reported
Vorherige Impfungen
-

VAERS 2672492

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
16.08.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

patient received vaccine at 16 and was given again when patient is 18

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
no adverse reactions
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2667201

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7616AB

gering
Staat
KY
Alter
11,0
Geschlecht
F
Eingang
08.08.2023
Impfdatum
27.07.2023
Beginn
27.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Medication error No adverse event

Symptomtext

administering Menquadfi to a patient and that the patient pulled back resulting in getting a partial dose, full dose was not able to be administered with no reported adverse event; Initial information received on 03-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves administering Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] to a 11 years old female patient and that the patient pulled back resulting in getting a partial dose, full dose was not able to be administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular, Tetanus Vaccine Toxoid (TDAP) for Prophylactic vaccination. On 27-Jul-2023, the patient while receiving a dose (1x) of suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine solution for injection (lot: U7616AB) with unknown strength & expiry date via unknown route in unknown administration site for Immunization and that the patient pulled back resulting in getting a partial dose, full dose was not able to be administered with no reported adverse event (incorrect dose administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
TDAP
Allergien
-
Vorherige Impfungen
-

VAERS 2652916

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7616AB

gering
Staat
ME
Alter
18,0
Geschlecht
M
Eingang
05.07.2023
Impfdatum
27.06.2023
Beginn
27.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

a dose of Menquadfi was administered to a patient that was supposed to receive meningococcal b (Bexsero) with no reported adverse event; a dose of Menquadfi was administered to a patient on 27jun2023, a previous dose of MCV4 was administered to the patient on 21jul2022 with no reported adverse event; Initial information received on 27-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 18 years old male patient to whom a dose of meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] was administered who was supposed to receive meningococcal vaccine B RFHBP/NADA/NHBA OMV (Bexsero) and a dose of Menquadfi was administered on 27-Jun-2023, a previous dose of mcv4 was administered on 21-Jul-2022 with no reported adverse event. The patient's past vaccination(s) included Meningococcal vaccine on 21-JUL-2022. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included Tetanus Vaccine for Prophylactic vaccination. On 27-Jun-2023, the patient received 0.5ml (dose 3) once of suspectmeningococcal A-C-Y-W135 (T CONJ) vaccine, solution for injection (strength: not reported) (lot U7616AB; Expiration date: 11-APR-2025) via intramuscular route in the left deltoid for Immunization who was supposed to receive meningococcal vaccine B RFHBP/NADA/NHBA OMV (Bexsero) with no reported adverse event (wrong product administered) and previous dose of mcv4 was administered to the patient on 21-Jul-2022 with no reported adverse event (inappropriate schedule of product administration) (latency: same day). Action : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2652237

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge u7616ab

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
04.07.2023
Impfdatum
27.06.2023
Beginn
27.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

menquadfi on 6/16/23 and then the same 2 vaccines administered 6/27/23 with no reported adverse event; Initial information received on 28-Jun-2023 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 11 years old male patient who received meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] on 6/16/23 and then the same vaccines on 6/27/23 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, tetanus vaccine toxoid (Adacel) for Prophylactic vaccination (immunization). On 27-Jun-2023, the patient again received 0.5 mL dose 1 of suspect meningococcal A-C-Y-W135 (T conj) vaccine, solution for injection (lot: u7616ab) (expiry date unknown) via intramuscular route in the right arm for immunization with no reported adverse event (inappropriate schedule of product administration) (same day latency). The patient had received Menquadfi vaccine 11 days prior at a different location. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event menquadfi on 6/16/23 and then the same 2 vaccines administered 6/27/23 with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA202758:01672015: related case for adacel

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649068

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7616AB

gering
Staat
MA
Alter
18,0
Geschlecht
M
Eingang
24.06.2023
Impfdatum
20.06.2023
Beginn
20.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

patient had third dose (two doses of Menactra prior to MENQUADFI that he was given today) with no reported adverse event; Initial information received on 20-Jun-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 18 years old male patient who received third dose (two doses of menactra prior to meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] that he was given today) with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine (HPV vaccine) for Immunisation. On 20-Jun-2023, the patient received 0.5 mL dose 3 of suspect meningococcal A-C-Y-W135 (T conj) vaccine, solution for injection (batch number: U7616AB; expiry date: 11-Apr-2025) via intramuscular route in the right deltoid for immunization (two doses of menactra prior to menquadfi that he was given today) with no reported adverse event (extra dose administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event patient had third dose (two doses of menactra prior to menquadfi that he was given today) with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648345

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

gering
Staat
MA
Alter
18,0
Geschlecht
M
Eingang
22.06.2023
Impfdatum
20.06.2023
Beginn
20.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was supposed to receive Men B vaccine and instead received MenQuadFi dose #3. Patient had no adverse reactions in the office. Patient left the office. Nurse Manage reviewed with manufacturer of vaccine and they stated to watch for side effects due to vaccine being administered at 2 years instead of 4 years post second dose. Dr. reviewed above with mother in the afternoon via phone. Mother aware and reported no side effects to MD. Mother will report any adverse effects to the office.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2641698

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7616AB

gering
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
06.06.2023
Impfdatum
06.06.2023
Beginn
06.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administration error

Symptomtext

Patient has severe allergy to Latex. Men B (Bexsero) was administered in an error. Patient called to ensure that she did not have any adverse reaction at 1:07 pm on 06/06/2023. Pt denied any adverse reaction at the time of call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None needed
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Allergies to Penicillin- Anaphylaxis Allergies to Latex-Shortness of breath
Vorherige Impfungen
-